Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 5Leukemia 4Lymphoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neuroblastoma 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Neoplasm Metastasis 1Melanoma 1Lymphoma, T-Cell 1Lymphoma, Large-Cell, Anaplastic 1Leukemia, Biphenotypic, Acute 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 18fludarabine 7Rituximab 7Etoposide 7Cytarabine 7Radiotherapy 5Peripheral Blood Stem Cell Transplantation 5Melphalan 5Filgrastim 5Cyclosporine 4Cisplatin 4fludarabine phosphate 3epratuzumab 3Vincristine 3Prednisone 3Methylprednisolone 3Indium 3Immunotherapy, Adoptive 3Doxorubicin 3Dexamethasone 3Busulfan 3Antilymphocyte Serum 3sargramostim 2Radioimmunodetection 2Paclitaxel 2Mycophenolic Acid 2Methotrexate 2Lym-1 monoclonal antibody 2Ifosfamide 2Hydrocortisone 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Burkitt Lymphoma × Vindesine × Clear all
NCT05049473 2021-09-20

Treatment of Mature B-ALL and Burkitt Lymphoma (BL) in Adult Patients. BURKIMAB-14.

PETHEMA Foundation

Phase 2 Unknown
100 enrolled
Lymphoid

Burkitt Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡